CardioTech
卡尤迪
CardioTech (卡尤迪) shows up in elsewhere's corpus only as a FreeS Fund portfolio company. Across several 峰瑞资本 (FreeS Fund) pieces from 2019–2021, the firm describes how, after its early bets, it moved into IVD, medical devices, and biotech — "投资新格元、卡尤迪、蓝晶微生物等公司" — placing CardioTech in that diagnostics/devices cluster . It also appears in FreeS Fund's broader portfolio list alongside companies like 晶泰科技 and 清陶发展 . Beyond the investment relationship, the corpus contains no detail on what exactly the company does, when it was founded, or its later rounds — elsewhere's coverage here is thin.
AI-generated — may contain errors, please verify.
Coverage
Spend a Summer on a VC Journey of "Seeking Truth" and "Taking Things Seriously" | FreeS Fund's 2024 Internship Program Is Now Open
Welcome aboard — a great workplace is one with a bunch of amazing colleagues.
Women Rising: 18 Voices from the World of Entrepreneurship | FreeS Fund International Women's Day Special
The traits that lead to success know no gender. May your journey of discovery be filled with wonder.
Our Year: Working Together, Staying the Course | FreeS Fund 2021 Year in Review
Walk alongside more outstanding founders.
New Opportunities Amid the Great Transformation in Drug R&D | FreeS Fund Dialogue Session 2 Now Open for Registration
Breakthroughs and Acceleration in New Drug R&D
FreeS Fund China-US Venture Forum Session 2 is still open for registration; FreeS Fund receives multiple recognitions from Langchao New Consumption, Joy Capital, and Qiming Technology & New Voice Innovation Service
Do what's right, not what's easy.
FreeS Fund Is Hiring Investors and Interns, Wins Multiple Awards from Forbes, TMTpost, CVCRI, and ToB Industry Network | Frees Fund Vol. 6
Do what's right, not what's easy.
Li Feng: One Chart to Decode Biotech Innovation Opportunities | Your Complete Guide to the FreeS Fund 2020 Biomedical Summit
Three Livestreams and One Offline Symposium, Decoding the Era of Biomedical Innovation
FreeS Fund Healthcare Open Day Is Here: Entering the Grand Era of Biomedical Innovation
Looking for China's Genentech, Moderna, Alnylam, Spark, Nimbus Therapeutics
In Our Sixth Year, FreeS Fund Is Hiring Investors | Let's Do What's Right, Not What's Easy
Betting on the power of innovation, staying research-driven.
FreeS Fund received eight recognitions from institutions including *Fortune* (Chinese edition), 36Kr, and the Fund of Funds Alliance.
Do what's right, not what's easy.
Our Past 100 Days: Sailing Against the Wind, Growing Toward the Sun
Venture Capital's Pandemic Fight: A Chronicle
Supporting the Fight Against the Novel Coronavirus: Our Actions and Call to Action | FreeS Fund
Let's come together and help the people of Hubei get through this difficult time.
Be Long-Term Greedy, Be a True Hero | FreeS Fund 2019 CEO Annual Meeting
Let's Go Further Together
